Skip to main content
. 2021 Sep 30;11:19429. doi: 10.1038/s41598-021-98582-9

Table 3.

Mitigation of secondary stress response (catalase and superoxide dismutase) through dietary supplementation of selenium nanoparticles, eicosapentanoic acid and dicosahexanoic acid fed to P. hypophthalmus reared in control or under arsenic and high temperature for 105 days.

Treatments Non-stressors Stressors (arsenic and temperature) Non-stressors Stressors (arsenic and temperature) P-value
Diets Control Control Se-NPs + EPA + DHA-0.2% Se-NPs + EPA + DHA-0.4% Se-NPs + EPA + DHA-0.6% Se-NPs + EPA + DHA-0.2% Se-NPs + EPA + DHA-0.4% Se-NPs + EPA + DHA-0.6%
CAT-Liver 3.96d ± 0.26 6.70f. ± 0.61 2.29c ± 0.19 0.91a ± 0.13 4.24e ± 0.31 2.13c ± 0.24 1.29b ± 0.11 6.39f. ± 0.18 0.0023
CAT-Gill 3.11c ± 0.40 8.44d ± 0.61 1.61b ± 0.25 0.78a ± 0.08 3.04c ± 0.53 1.52b ± 0.28 0.81a ± 0.07 3.21c ± 0.59 0.014
CAT-Kidney 5.73c ± 0.76 9.01d ± 0.38 2.68b ± 0.29 1.04a ± 0.15 5.09c ± 0.41 2.22b ± 0.31 1.20a ± 0.19 9.47d ± 0.92 0.002
SOD-Liver 66.0b ± 1.82 75.04d ± 1.14 66.71b ± 1.16 62.02a ± 1.13 70.85c ± 1.09 66.75b ± 1.50 62.59a ± 0.58 72.07c ± 0.91 0.034
SOD-Gill 31.49a ± 1.23 38.71b ± 0.58 30.63a ± 1.44 32.01a ± 1.40 30.31a ± 1.84 32.26a ± 0.80 30.15a ± 1.96 30.84a ± 1.46 0.027
SOD-Kidney 41.16a ± 1.29 46.66b ± 2.16 42.32a ± 1.54 40.57a ± 0.98 43.34ab ± 1.25 40.97a ± 0.95 41.0a ± 1.52 47.15b ± 1.46 0.043

Values in the same row with different superscript (a, b, c, d, e, f) differ significantly. Data expressed as Mean ± SE (n = 6). Catalase and SOD: Units/mg protein.